Silence Therapeutics plc

SLN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$121,330$68,789$54,816$73,537
Short-Term Investments$26,004$0$16,328$0
Receivables$26,908$23,977$915$331
Inventory$0$0$0$0
Other Curr. Assets$13,124$10,385$24,627$12,465
Total Curr. Assets$187,366$103,151$96,686$86,333
Property Plant & Equip (Net)$1,975$2,308$2,201$1,944
Goodwill$9,392$9,981$8,009$7,592
Intangibles$312$362$320$24
Long-Term Investments$0$0$284$301
Tax Assets$0$0$0$0
Other NC Assets$3,590$3,646$0$0
Total NC Assets$15,269$16,297$10,814$9,861
Other Assets$0$0$0$0
Total Assets$202,635$119,448$107,500$96,194
Liabilities
Payables$3,697$3,348$3,186$4,065
Short-Term Debt$117$228$446$137
Tax Payable$896$476$0$0
Deferred Revenue$306$6,571$0$0
Other Curr. Liab.$11,806$11,714$18,311$10,965
Total Curr. Liab.$16,822$22,336$21,943$15,167
LT Debt$0$118$0$0
Deferred Rev, NC$51,790$75,001$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$63,485$72,501
Total NC Liab.$51,790$75,119$63,485$72,501
Other Liabilities$0$0$0$0
Cap. Leases$117$118$446$137
Total Liabilities$68,612$97,455$85,428$87,668
Equity
Pref Stock$0$0$0$0
Common Stock$10,288$8,847$5,390$4,489
Retained Earnings-$474,044-$431,894-$263,263-$222,966
AOCI-$11,781$40,361$53,275$42,671
Other Equity$609,560$404,679$226,670$184,332
Total Equity$134,023$21,993$22,072$8,526
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$202,635$119,448$107,500$96,194
Net Debt-$121,213-$68,443-$54,370-$73,400